InNexus Biotechnology (InNexus Biotechnology) Gross Margin % : 0.00% (As of Mar. 2011)

InNexus Biotechnology Gross Margin % Chart

InNexus Biotechnology Annual Data
	Trend	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10
Gross Margin %		Get a 7-Day Free Trial					-	-	-	-	-

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Gross Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of InNexus Biotechnology's Gross Margin %

For the Biotechnology subindustry, InNexus Biotechnology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Gross Margin % distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Gross Margin % falls into.

InNexus Biotechnology Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

InNexus Biotechnology's Gross Margin for the fiscal year that ended in Jun. 2010 is calculated as

InNexus Biotechnology's Gross Margin for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

InNexus Biotechnology  (GREY:IXSBF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

InNexus Biotechnology had a gross margin of N/A% for the quarter that ended in Mar. 2011 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

InNexus Biotechnology Gross Margin % Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description